Bionano Genomics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
/ 
Frequently asked questions
To buy Bionano Genomics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bionano Genomics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bionano Genomics Inc. is BNGO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bionano Genomics Inc. has its primary listing on NASDAQ (Small cap). You can trade Bionano Genomics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bionano Genomics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Bionano Genomics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Bionano Genomics Inc..